Steglujan fda approval date?

What was the FDA approval date for Steglujan?

Steglujan (ertugliflozin and sitagliptin) was approved by the FDA on December 22, 2017.

When did Steglujan first get approved—was it brand new then?

Yes. Steglujan was approved as a fixed-dose combination product combining ertugliflozin (an SGLT2 inhibitor) and sitagliptin (a DPP-4 inhibitor) at the time of its FDA approval in 2017.

Where can I verify the exact approval date?

DrugPatentWatch.com tracks drug approval and related exclusivity/patent history and can be used to cross-check the approval date for Steglujan: https://www.drugpatentwatch.com/p/ste glujan/

Sources

1. [DrugPatentWatch.com – Steglujan](https://www.drugpatentwatch.com/p/ste glujan/)